![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 10
2017
Kruger, Stephan; Haas, Michael; Burkl, Carolin; Goehring, Peter; Kleespies, Axel; Röder, Falk; Gallmeier, Eike; Ormanns, Steffen; Westphalen, Christoph Benedikt; Heinemann, Volker; Rank, Andreas und Boeck, Stefan
(2017):
Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
In: Thrombosis Research, Bd. 157: S. 9-15
2016
Hocke, Sandra; Guo, Yang; Job, Albert; Orth, Michael; Ziesch, Andreas; Lauber, Kirsten; De Toni, Enrico N.; Gress, Thomas M.; Herbst, Andreas; Göke, Burkhard und Gallmeier, Eike
(2016):
A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers.
In: Oncotarget, Bd. 7, Nr. 6: S. 7080-7095
De Toni, Enrico N.; Ziesch, Andreas; Rizzani, Antonia; Török, Helga-Paula; Hocke, Sandra; Lü, Shuai; Wang, Shao-Chun; Hucl, Tomas; Göke, Burkhard; Bruns, Christiane und Gallmeier, Eike
(2016):
Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis.
In: Oncotarget, Bd. 7, Nr. 8: S. 9478-9491
2015
Guo, Yang; Ziesch, Andreas; Hocke, Sandra; Kampmann, Eric; Ochs, Stephanie; De Toni, Enrico N.; Göke, Burkhard und Gallmeier, Eike
(2015):
Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.
In: Journal of Cellular and Molecular Medicine, Bd. 19, Nr. 2: S. 340-350
[PDF, 985kB]
2014
Hirschi, Benjamin; Gallmeier, Eike; Ziesch, Andreas; Marschall, Maximilian und Kolligs, Frank T.
(2014):
Genetic targeting of B-Raf(V600E) affects survival and proliferation and identifies selective agents against BRAF-mutant colorectal cancer cells.
In: Molecular Cancer
13:122
[PDF, 3MB]
2013
Gallmeier, Eike; Bader, Dominik C.; Kriegl, Lydia; Berezowska, Sabina; Seeliger, Hendrik; Göke, Burkhard; Kirchner, Thomas; Bruns, Christiane und De Toni, Enrico N.
(2013):
Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.
In: PLOS ONE 8(2), e56760 [PDF, 785kB]
In: PLOS ONE 8(2), e56760 [PDF, 785kB]
2012
Kriegl, Lydia; Jung, Andreas; Horst, David; Rizzani, Antonia; Jackstadt, Rene; Hermeking, Heiko; Gallmeier, Eike; Gerbes, Alexander L.; Kirchner, Thomas; Göke, Burkhard und De Toni, Enrico N.
(2012):
Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer.
In: PLOS ONE 7(12), e51654 [PDF, 646kB]
In: PLOS ONE 7(12), e51654 [PDF, 646kB]
2010
Palagyi, Andreas; Neveling, Kornelia; Plinninger, Ursula; Ziesch, Andreas; Targosz, Bianca-Sabrina; Denk, Gerald U.; Ochs, Stephanie; Rizzani, Antonia; Meier, Daniel; Thasler, Wolfgang E.; Hanenberg, Helmut; De Toni, Enrico N.; Bassermann, Florian; Schaefer, Claus; Göke, Burkhard; Schindler, Detlev und Gallmeier, Eike
(2010):
Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.
In: Molecular Cancer
9:127
[PDF, 1MB]
2009
Mucha, Simon R.; Rizzani, Antonia; Gerbes, Alexander L.; Camaj, Peter; Thasler, Wolfgang E.; Bruns, Christiane; Eichhorst, Sören T.; Gallmeier, Eike; Kolligs, Frank T.; Göke, Burkhard und De Toni, Enrico
(2009):
JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.
In: Gut, Bd. 58: S. 688-698
[PDF, 912kB]
Boeck, Stefan; Metzeler, Klaus H.; Hausmann, Andreas; Baumann, Anja; Gallmeier, Eike; Parhofer, Klaus G. und Stemmler, Hans-Joachim
(2009):
Cisplatin-Based Chemotherapy for Pulmonary Metastasized Germ Cell Tumors of the Testis - Be Aware of Acute Respiratory Distress Syndrome.
In: Onkologie, Nr. 3: S. 125-128
[PDF, 111kB]